A 35-year-old man with rheumatic mitral stenosis and a 28-year-old woman with a bicuspid aortic valve both present with fever and a new regurgitant murmur. Blood cultures from both are positive for Streptococcus viridans. Which feature best distinguishes acute bacterial endocarditis from subacute bacterial endocarditis?

Explanation

## Acute vs. Subacute Bacterial Endocarditis: Key Discriminators ### Rapidity of Valve Destruction as the Primary Discriminator **Key Point:** The feature that **best distinguishes** acute bacterial endocarditis (ABE) from subacute bacterial endocarditis (SBE) is the *rapidity of valve destruction and hemodynamic decompensation*: - **Acute IE:** Fulminant course over days to weeks; caused by virulent organisms (S. aureus, S. pyogenes, Gram-negative bacilli, fungi); leads to rapid valve destruction, acute regurgitation, and hemodynamic collapse. - **Subacute IE:** Indolent course over weeks to months; caused by less virulent organisms (Streptococcus viridans, S. bovis, Enterococcus, HACEK group); gradual valve damage with slower hemodynamic deterioration. This distinction is the **defining clinical hallmark** used in standard textbooks (Harrison's Principles of Internal Medicine, 21st ed.; Robbins & Cotran Pathologic Basis of Disease, 10th ed.) to separate the two syndromes. ### Comparison Table: Acute vs. Subacute IE | Feature | Acute IE | Subacute IE | |---------|----------|-------------| | **Onset/Course** | Fulminant; days to weeks | Insidious; weeks to months | | **Valve destruction** | Rapid; acute regurgitation, shock | Gradual; progressive regurgitation | | **Common organisms** | S. aureus, S. pyogenes, GNB, fungi | Strep viridans, S. bovis, Enterococcus, HACEK | | **Valve substrate** | Often normal, but can be abnormal | Usually abnormal/damaged valve | | **Emboli** | Septic emboli (lungs, brain, spleen) | Sterile/immune emboli (splinter hemorrhages, Osler nodes) | | **Mortality** | 20–40% (even with treatment) | 5–15% (with appropriate therapy) | ### Why Option B Is Correct **High-Yield:** The rapidity of valve destruction and hemodynamic decompensation is the **cardinal distinguishing feature** between ABE and SBE. ABE destroys valves within days, causing acute regurgitation and cardiogenic shock, while SBE causes gradual valve damage over months. This is the primary clinical and pathological distinction emphasized in Harrison's and Robbins. ### Why the Other Options Are Incorrect **Option A – Embolic phenomena (splinter hemorrhages, Osler nodes):** These immune complex–mediated phenomena occur in **both** ABE and SBE. They are more prominent in SBE due to the longer duration of bacteremia, but their presence does not reliably distinguish the two syndromes. **Option C – Positive blood cultures on first draw:** Blood culture positivity on the first draw can occur in both ABE and SBE. While high-grade bacteremia is more common in ABE (e.g., S. aureus), SBE can also yield positive cultures on initial sampling. This is not a reliable discriminator. **Option D – Involvement of previously normal valves:** While ABE has a *tendency* to infect normal valves and SBE tends to infect abnormal valves, this is not an absolute rule. As demonstrated in this very stem, SBE (Strep viridans) can infect abnormal valves (rheumatic MS, bicuspid AV), and ABE (S. aureus) can also infect previously damaged valves. The valve substrate is a *predisposing factor*, not the defining clinical discriminator between the two syndromes. **Clinical Pearl:** The terms "acute" and "subacute" themselves refer to the **tempo of illness** — i.e., how rapidly the disease progresses — making rapidity of valve destruction and hemodynamic decompensation the most accurate and textbook-supported distinguishing feature (Harrison's, 21st ed., Chapter 123).